15 | RadiopharmaceuticalsIBA
12/2020
-
07/2012 |
13 | Peptides (Polypeptides)IBA
01/2020
-
12/2012 |
11 | AcidsIBA
10/2020
-
11/2013 |
10 | Biological ProductsIBA
01/2021
-
02/2013 |
10 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
11/2019
-
02/2013 |
9 | Radioisotopes (Radionuclides)IBA
01/2020
-
09/2013 |
6 | IntegrinsIBA
12/2020
-
01/2015 |
6 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
10/2019
-
02/2018 |
5 | PorphyrinsIBA
03/2021
-
11/2013 |
5 | Monoclonal AntibodiesIBA
10/2020
-
12/2012 |
5 | LigandsIBA
01/2020
-
01/2017 |
5 | 1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid) (DOTMP)IBA
01/2019
-
02/2014 |
4 | DNA (Deoxyribonucleic Acid)IBA
03/2021
-
01/2017 |
4 | arginyl-glycyl-aspartic acidIBA
12/2020
-
02/2013 |
4 | Pentetic Acid (DTPA)FDA LinkGeneric
10/2020
-
01/2016 |
4 | 1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
03/2020
-
01/2017 |
4 | ribosomal protein S30IBA
01/2020
-
01/2017 |
4 | Chelating AgentsIBA
09/2019
-
02/2018 |
3 | Trastuzumab (Herceptin)FDA Link
03/2021
-
01/2017 |
3 | N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
12/2019
-
03/2017 |
3 | Rituximab (Mabthera)FDA Link
11/2019
-
08/2015 |
3 | GE 68IBA
09/2019
-
02/2013 |
3 | NGR peptideIBA
07/2019
-
01/2017 |
3 | Pharmaceutical PreparationsIBA
05/2018
-
01/2017 |
3 | Somatostatin Receptors (Somatostatin Receptor)IBA
12/2017
-
04/2017 |
3 | Peptide Receptors (Peptide Receptor)IBA
09/2017
-
03/2015 |
2 | N- (2- amino- 3- (para- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N,N',N',N'- pentaacetic acidIBA
10/2020
-
08/2015 |
2 | human ERBB2 proteinIBA
10/2020
-
04/2020 |
2 | Intercalating AgentsIBA
01/2020
-
01/2020 |
2 | ubiquicidin 31-38IBA
01/2020
-
07/2018 |
2 | aspartic acid glycine arginineIBA
09/2019
-
06/2015 |
2 | cyclic arginine-glycine-aspartic acid peptideIBA
05/2019
-
02/2013 |
2 | EndotoxinsIBA
03/2019
-
06/2015 |
2 | Rhenium-188IBA
10/2018
-
07/2012 |
2 | Etidronic Acid (HEDP)FDA LinkGeneric
10/2018
-
06/2017 |
2 | Ethiodized Oil (Ethiodol)FDA Link
07/2018
-
02/2017 |
2 | Gallium-68IBA
07/2018
-
09/2016 |
2 | NucleosidesIBA
05/2018
-
09/2017 |
2 | GemcitabineFDA Link
05/2018
-
09/2017 |
2 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2017
-
01/2016 |
2 | Bevacizumab (Avastin)FDA Link
05/2017
-
01/2016 |
2 | Durapatite (Hydroxylapatite)IBA
10/2016
-
06/2014 |
2 | Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
04/2015
-
03/2015 |
1 | CamptothecinIBA
07/2021 |
1 | Cisplatin (Platino)FDA LinkGeneric
04/2021 |
1 | ProdrugsIBA
04/2021 |
1 | tetra(4-N-methylpyridyl)porphineIBA
03/2021 |
1 | 1-phenyl-3,3-dimethyltriazene (PDT)IBA
03/2021 |
1 | protein KIBA
03/2021 |
1 | Antigen Receptors (Antigen Receptor)IBA
03/2021 |
1 | ThiadiazolesIBA
01/2021 |
1 | ThioureaIBA
01/2021 |
1 | benzothiazoleIBA
01/2021 |
1 | N- (2- amino- 3- (4- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N',N',N'',N''- pentaacetic acidIBA
10/2020 |
1 | Immunoconjugates (Immunoconjugate)IBA
04/2020 |
1 | Aluminum Oxide (Sapphire)IBA
02/2020 |
1 | SolutionsIBA
02/2020 |
1 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 |
1 | DisulfidesIBA
01/2020 |
1 | EstersIBA
01/2020 |
1 | Sulindac (Copal)FDA LinkGeneric
01/2020 |
1 | Aminacrine (Aminoacridine)IBA
01/2020 |
1 | AcridinesIBA
01/2020 |
1 | Antimicrobial PeptidesIBA
01/2020 |
1 | Glucose (Dextrose)FDA LinkGeneric
01/2020 |
1 | Glutathione (Reduced Glutathione)IBA
01/2020 |
1 | Galectin 3 (LGALS3)IBA
01/2020 |
1 | A-Form DNA (A-DNA)IBA
01/2020 |